« Postpsychotic depression » and residual schizophrenia in a mental health hospital

Encephale

Volumn 26, Issue 6, 2000, Pages 21-26

  Mauri, M C ^a   Laini, V ^a   Barone, R ^b   Clemente, A ^a   Volonteri, L S ^a   Cerveri, G ^a   Steinhilber, C ^a   Fornier, M ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b Mental Health Hospital   (Italy)

Author keywords

Chronicity; Neuroleptic treatments; Postpsychotic depression; Schizophrenia

Indexed keywords

BIPERIDEN; CLOZAPINE; DIAZEPAM; HALOPERIDOL; NEUROLEPTIC AGENT;

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CLINICAL EXAMINATION; CONTROLLED STUDY; DEPRESSION; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MENTAL HOSPITAL; MINI MENTAL STATE EXAMINATION; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGIC TEST; RATING SCALE; SCHIZOPHRENIA; COMORBIDITY; CROSS-SECTIONAL STUDY; MIDDLE AGED; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; RISK FACTOR;

ADULT; AGED; ANTIPSYCHOTIC AGENTS; CHRONIC DISEASE; COMORBIDITY; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0034351989     PISSN: 00137006     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Mortality in schizophrenia
2. Fluphenazine decanoate in acute and maintenance therapy of schizophrenia
3. Residual neuroleptic-induced parkinsonian symptoms in schizophrenia. A naturalistic study with orphenadrine
4. Depressive symptoms in chronic schizophrenia: Clinical and pharmacological variables
5. Suicide and schizophrenia: Data from a prospective community treatment study
6. Differentiating the effects of centrally acting drugs on arousal and memory: An event-related pontential study of scopolamine, lorazepam and diphenhydramine
7. Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician
8. The diagnostic ambiguity of post-psychotic depression
9. Alertness and memory after sleep deprivation and diazepam intake
10. A rating scale for depression
11. Out patients maintenance of chronic schizophrenic patients with long acting fluphenazine: Double-blind placebo trial
12. Depression « revealed » in schizophrenia
13. Studies of depressive symptoms in schizophrenia: The prevalence of depression and its possible causes
14. Negative and depressive symptoms in schizophrenia
15. Development and prediction of postpsychotic depression in neuroleptic-treated schizophrenics
16. Depression in schizophrenia: Clinical and pharmacological variables
17. Depression and schizophrenia: A psychopharmacological approach
18. Depressive symptoms and schizophrenic relapses: The effect of four neuroleptic drugs
19. An investigation of the postpsychotic depressive syndrome
20. Postpsychotic depression in schizophrenia
21. Patterns of self-destructive behavior in schizophrenia
22. Brief psychiatric rating scale
23. Akinesia poorly recognized drug-induced extrapyramidal disorder
24. The seemingly ubiquitous depression following acute schizophrenic episodes, a neglected area of clinical discussion
25. Depression during the longitudinal course of schizophrenia
26. Relationship among negative, positive and depressive symptoms in schizophrenia and psychotic depression
27. A rating scale for extrapyramidal side-effects
28. Postpsychotic depression and negative symptoms. An investigation of syndromal overlap
29. Research diagnostic criteria: Rationale and reliability
30. Postpsychotic depression in schizophrenics
31. Cognitive impairment and benzodiazepines
32. Natural course of schizophrenic disorders: A 15 year followup of a dutch incidence cohort
33. Depressive symptoms in schizophrenia